SMI Adviser Clozapine Center of Excellence

This component of SMI Adviser focuses on increasing and improving the use of clozapine in treatment refractory schizophrenia. The Clozapine COE provides resources, CME/NCPD-certified education, and clinical consultations. Join the Clozapine COE community and sign up for the SMI Adviser newsletter below to stay updated on new content.

The Clozapine COE is led by SMI Adviser Physician Expert, Alexander Young, MD, MSHS, and SMI Adviser content partner, National Association of State Mental Health Program Directors (NASMHPD), and supported by members of the Clozapine Workgroup: Brian M. Hepburn, MD; Donna Rolin, PhD, APRN; Robert O. Cotes, MD; Raymond C. Love, PharmD, BCPP, FASHP; Deanna L. Kelly, PharmD, BCPP; Doris A. Fuller, MFA; Anthony Battista, MD, MPH; and Gopal Vyas, DO.

For patient and family resources on using clozapine, visit the patient and family Knowledge Base.

Join the SMI Adviser Clozapine COE Community

The Clozapine COE listserv engages psychiatrists, nurses, pharmacists, and other clinicians to provide an opportunity for collaborating on the use of clozapine. Sign up for the listserv and join the conversation!

Sign up now

Clozapine Resources

Browse resources and find answers from the SMI Adviser Knowledge Base


Request a Consultation

Our clinical experts can answer questions about SMI from all mental health clinicians. Ask us about psychopharmacology, therapies, recovery supports, patient and family engagement, education, and much more.

Submit Now

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts